Cognivia develops analytical tools to optimize and speed the clinical development of novel medicines.
Cognivia has raised $16.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.
Cognivia's investors include Vesalius Biocapital Partners, SFPIM, Innovation Fund, WE International, Sambrinvest.
Cognivia is headquartered in Mont-saint-guibert, Belgium.
Cognivia develops analytical tools to optimize and speed the clinical development of novel medicines.
Cognivia is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cognivia — Funding & Investors." VCBacked, April 18, 2024, https://www.vcbacked.co/company/cognivia. Accessed August 18, 2026.
VCBacked. (2024). Cognivia — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/cognivia
{{cite web |title=Cognivia — Funding & Investors |url=https://www.vcbacked.co/company/cognivia |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated